• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $RGA

    Reinsurance Group of America Incorporated

    Subscribe to $RGA
    $RGA
    Life Insurance
    Finance

    Reinsurance Group of America, Incorporated engages in reinsurance business. It offers individual and group life and health insurance products, such as term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability, and longevity products; asset-intensive and financial reinsurance products; and other capital motivated solutions. The company also provides reinsurance for mortality, morbidity, lapse, and investment-related risk associated with products; and reinsurance for investment-related risks. In addition, it develops and markets technology solutions; and provides consulting and outsourcing solutions for the insurance and reinsurance industries. The company serves life insurance companies in the United States, Latin America, Canada, Europe, the Middle East, Africa, Australia, and the Asia Pacific. Reinsurance Group of America, Incorporated was founded in 1973 and is headquartered in Chesterfield, Missouri.

    IPO Year:

    Exchange: NYSE

    Website: rgare.com

    Recent Analyst Ratings for Reinsurance Group of America Incorporated

    DatePrice TargetRatingAnalyst
    5/23/2025Strong Buy → Mkt Perform
    Raymond James
    4/2/2025$216.00Buy → Neutral
    UBS
    4/2/2025$237.00Neutral → Overweight
    Analyst
    10/9/2024$235.00Hold
    TD Cowen
    9/5/2024$255.00Overweight
    Barclays
    12/11/2023$171.00 → $189.00Hold → Buy
    Jefferies
    6/23/2023$170.00 → $160.00Buy → Hold
    Jefferies
    6/7/2023$199.00Strong Buy
    Raymond James
    4/25/2023$163.00Overweight
    Wells Fargo
    3/15/2023$133.00 → $158.00Sell → Buy
    Citigroup
    See more ratings